The DNA Sequencing Market was worth US$ 5.2 Billion in 2019 and is expected to grow at a CAGR of 10.4% through 2030.
DNA sequencing refers to the process of identification of sequence of nucleotides (adenine (A), cytosine (C), guanine (G), thymine (T), and uracil (U)) in the DNA. DNA Sequencing allows the investigation of particular genetic illness or diseases. Although there is more than one method of carrying DNA sequencing, the basic task of these methods includes breaking down the long DNA strands into small pieces that would make the researches easy to analyze the order of the nucleotide bases in that small piece.
DNA Sequencing also plays an important role in pharmaco-genomics. Pharmacogenomics is a field which studies how genes affect a person’s ability to respond to drugs. Study of pharmacogenomics is necessary to determine which drug will provide the best outcome in patient. DNA sequencing can be used to identify the possible mutations in the genes that could cause the disease to grow more aggressively.
Identification on these mutations will allow the medical practitioners to treat them with specific drugs that could target these mutations and prevent the growth of the cell deformation in the body. Apart from being used by the medical professional facilities, DNA sequencing is also used by the forensics department all over the world to give justice to many critical crime related cases.
North America has the major share in the global DNA sequencing market. Rising funding for the healthcare research capabilities is one of the major factors supporting the growth of the market. The Centers for Medicare & Medicaid Services (CMS) in the published report stated that in 2019, United States healthcare spending reached US$ 3.8 trillion. Company further stated that the spending would reach US$ 4 trillion in 2020 and around US$ 6 trillion in 2028.
Asia Pacific would be the fastest growing regions among the others throughout the forecast period of 2020-2030. China continues to increase its spending over R&D activities thus providing support to the life sciences company to continue the clinical trials that could change the genetics industry drastically. In 2019, China’s science and technology expenditure reached up to US$ 322 billion which was 12.5% more than the previous year spending. South America followed by Middle East & Africa will also see some considerable growth in the global DNA sequencing during the forecast period.
DNA Sequencing Market Value Share Analysis, by Geography (2022)
The report titled “DNA sequencing Market- Global Market Share, Trends, Analysis and Forecasts, 2022-2032” wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global DNA sequencing market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global DNA sequencing market is segmented into product, sequencing type, end-user, applications and geography. On the basis of product type the market is segmented into devices & equipment, software and services. Sequencing type segment is further bifurcated into Sanger sequencing, next-generation sequencing and third generation sequencing. Next-generation sequencing is further segmented into whole genome sequencing, whole exome sequencing and targeted sequencing & resequencing. Furthermore, third generation sequencing is segmented into Single-Molecule Real-Time Sequencing (SMRT) and Nanopore Sequencing. Next generation sequencing technology segment dominated the market throughout the forecast period. Declining cost and time needed for the sequencing while maintaining the accuracy increases its demand in the market. Next generation sequencing methods also helps in solving complicated and difficult criminal cases by analyzing and providing enormous amount of data (autosomes, mitochondrial chromosomes, etc.). On the basis of end-user the global DNA sequencing market is bifurcated into hospitals & clinics, academic research, clinical research facilities, enterprises and others. Enterprises are further segmented into pharmaceutical companies and biotechnology companies. Based on applications the market is segmented into reproductive Health, Clinical Investigation (drug development, epidemiology prevention, etc.), Forensics, consumer genomics and others.
Based on geography, the global DNA sequencing market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, South Korea, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global DNA sequencing market with a focus on all operating business segment and would identify and analyze the segment of the company focusing on DNA sequencing. Further, market share of prominent companies in the global DNA sequencing market would also be estimated. The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focusing on the DNA sequencing activities.
The global DNA sequencing market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products and innovations regarding DNA sequencing segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new innovations and patent filing information and geographic expansion in the global DNA sequencing market.
Major players active in the global DNA sequencing market include Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Macrogen, Inc., Pacific Biosciences of California, Inc., Bio-Rad Laboratories, Inc., PierianDx, Eurofins Scientific, Thermo Fisher Scientific, Inc., QIAGEN, Oxford Nanopore Technologies Ltd., Perkin Elmer, Inc., BGI., Myriad Genetics and Intrexon Bioinformatics Germany GmbH.
Segmentation:
By Product
By Sequencing type
By End-user
By Applications
By Geography
The base year considered in DNA sequencing market report is 2021.
The global market for DNA sequencing will most likely expand at over 10.4% CAGR through 2030.
North America has the major share in the global DNA sequencing market. Rising funding for the healthcare research capabilities is one of the major factors supporting the growth of the market.
Based on type, the sequencing type market is segmented into Sanger sequencing, next-generation sequencing and third generation sequencing.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved